Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ranbaxy has recalled its generic version of cholesterol-lowering drug Lipitor from the US market.
Subscribe to our email newsletter
The company has neither revealed the reasons for the call back nor mentioned the facility from where the recalled products were manufactured.
The Business Today cited Ranbaxy’s BSE filing as saying that the company has made a recall of Atorvastatin from the US market leading to temporary disruption of the product in the US market.
"The investigation with regard to the same… is expected to be completed within two weeks and thereafter the company expects to resume supplies," BSE filing added.
The company supplies the generic version of Lipitor to the US market from its two facilities – India-based Mohali plant and US-based Ohm Laboratories.
Ranbaxy has recalled a particular batch consisting of 10mg, 20mg and 40mg tablets from the US market, according to the news agency.
The company had launched generic atorvastatin in the US market in December 2012.